
-
Dutch girl footballers tackle crippling knee injuries
-
Nintendo's Switch 2 scores record early sales
-
ECB's Lagarde slams 'coercive trade policies' in Beijing visit
-
UK expected to boost defence, health in major spending review
-
Larkham says Brumbies peaking at right time ahead of Super Rugby semi
-
Man-in-demand Woodkid composes for Death Stranding sequel
-
Monsoon-loving Indian expats chase rain in UAE desert
-
Former student kills 10 in Austrian high school shooting
-
Australian murder suspect denies drying deadly mushrooms
-
A step too far? New Club World Cup set to have far-reaching impact on football
-
Rare earths: China's trump card in trade war with US
-
South Africa aim to banish choker tag in WTC final against Australia
-
Trump orders names restored to military bases honoring Confederates
-
Wallabies coach Schmidt hails 'leader' Gordon ahead of Lions tour
-
Tears, tattoos, Cartier watches: fan frenzy at BTS army discharge
-
Pochettino problems mount as US routed 4-0 by Switzerland
-
Mapping Ireland's peatlands to help cut carbon emissions
-
Brazil book World Cup berth, Uruguay on brink
-
French Tesla customers sue over brand becoming 'extreme right'
-
Toxic Thailand rivers pinned on Myanmar mines
-
Asian equities rally after China-US framework on trade
-
Nintendo says sold record 3.5m Switch 2 consoles in first four days
-
Son to 'wait and see' on Tottenham future after Saudi links
-
'Applied AI' set to dominate France's Vivatech trade fair
-
Two more BTS megastars released from South Korea military service
-
Nighttime curfew in LA as Trump vows to 'liberate' city
-
Ukraine says Russian strikes hit Kharkiv, killing two
-
Australia reach World Cup as Palestinian dreams ended
-
Experts warn Canada's wildfire season likely to be massive again
-
How have teams qualified for the Club World Cup?
-
US, China agree on trade 'framework' after high-level talks
-
N.Ireland town hit by second night of unrest
-
Fifth day of protests in LA as Trump vows to 'liberate' city
-
Agronomics Q2 2025 Newsletter
-
US slams sanctions by UK, allies on far-right Israeli ministers
-
Cristina Kirchner: divisive left-winger tainted by fraud
-
Argentine top court upholds ex-president Kirchner's prison sentence
-
Haliburton dismisses injury fears ahead of Thunder clash
-
Treasury chief returns to US as China trade talks ongoing
-
Duckett stars as England complete T20 sweep against West Indies
-
Scheffler seeks back-to-back major wins at formidable Oakmont
-
No panic, but England 'not good enough', says Kane
-
Netherlands thrash Malta, Poland stumble in World Cup qualifying
-
Hope recalled for West Indies Test series against Australia
-
Teen pleads 'not guilty' to shooting Colombian presidential candidate
-
Brazil's Bolsonaro rejects charges in coup trial
-
England stunned by Senegal to put Tuchel under immediate pressure
-
Combs defense seeks to show ex-girlfriend had agency
-
Seven dead as Colombia hit with wave of bombings and gun attacks
-
DeChambeau eyes new LIV deal ahead of US Open defence

DEA DIVERSION Scandal Exposed - Marijuana Drug Development Obstruction
DEA Back to Training School, DEA Bureaucrat Blocks Science While Ignoring their Own TRAINING Manual.
DEA Assistant Administrators and attorney needs a summer assignment, and MMJ BioPharma Cultivation has a suggestion: go back and read your own policy statement and training manual.
WASHINGTON, DC / ACCESS Newswire / June 10, 2025 / The DEA Diversion divisioncast of clowns needs a summer assignment and MMJ BioPharma Cultivation has a suggestion: go back and read your own mission statement and training manual.

For years, the DEA DEPUTY Administrator has been the face of obstruction inside the DEA's Diversion Control Division, using his signature to delay, deny, and destroy federally compliant scientific research-including the case of MMJ BioPharma Cultivation, which has been blocked from developing pharmaceutical-grade cannabis for over 2,300 days.
But now, documents from the DEA's own internal guidance-Sections 5202.5 and 5201.12 of the Diversion Control Manual-expose a truth that Prevoznik either doesn't understand or is deliberately ignoring:
The DEA is required to support bona fide Schedule I research, expedite applications, and allow legitimate brokers to process international shipments without registering as importers.
Yet under DEA's direction, the DEA has done exactly the opposite.
Section 5202.5: The DEA Policy Prevoznik Pretends Doesn't Exist
Let's review what the DEA's own policy says:
"DEA Fully Supports Bona Fide Research Utilizing Schedule I Controlled Substances For legitimate purposes."
"DEA works closely with the FDA and the National Institute of Health to ensure that research applications are approved expeditiously."
"Every effort should be made to expedite any applications for schedule I research from legitimate individuals."
So why did the DEA deny MMJ BioPharma's Corrective Action Plan without offering any path forward?
Why has the DEA:
Delayed MMJ's cannabis manufacturing registration for 7 years?
Forced unconstitutional ALJ hearings?
Refused to recognize FDA orphan drug designations?
Sabotaged legitimate research despite a clear mandate to "expedite" it?
Either the diversion administrators were sleeping in school, skipped this section of the manual-or he's actively violating it.
Section 5201.12: The International Hypocrisy
DEA's blockade doesn't stop at domestic research. In an absurd twist of hypocrisy, the DEA allows international corporations to export and import Schedule I substances using unregistered brokers, as long as a DEA-registered entity is involved.
Per Section 5201.12:
"A controlled substance import/export broker who handles paperwork and makes shipping arrangements, but does not take possession, is not required to register with the DEA."
So why is the DEA targeting companies like MMJ BioPharma Cultivation, which have followed every step of the law, while ignoring large recreational marijuana firms illegally shipping Schedule I substances overseas?
The answer is clear: this isn't about compliance. It's about bias, control and corruption.
DEA 's Real Mission: Delay, Not Diversion
While DEA's published mission is to "ensure an adequate and uninterrupted supply" of controlled substances for medical and scientific needs, Prevoznik has twisted that mandate into a blockade.
The DEA is:
Violating federal law including the Medical Marijuana and Cannabidiol Research Expansion Act
Ignoring President Trump's Right to Try Act
Defying Supreme Court precedent by pushing unconstitutional ALJs
And sabotaging lawful, FDA-aligned companies like MMJ BioPharma
This isn't just unethical. It's a direct betrayal of the DEA's own rulebook.
The DEA Administrator Must Send His Diversion Agents Back to School-or Out the Door
As DEA Administrator nominee Terry Cole prepares to take the reins, he must make a choice: allow bureaucratic sabotage to continue, or restore the agency's credibility by enforcing the policies already in writing.
That means:
Terminating agent's role in cannabis and psilocybin oversight
Auditing all denied Schedule I research applications since 2018
Restoring MMJ BioPharma's registration rights
Enforcing DEA's own internal policies as written in 5202.5 and 5201.12
Because the only thing more dangerous than violating the law is violating it while pretending you're upholding it.
Time to Graduate from the DEA Obstruction Schoolhouse
DEA Diversion and the cast of clowns has had two decades to learn how to administer the DEA's mission. Instead, he's rewritten it behind closed doors, with zero transparency, and at the expense of patients, science, and federal law.
DEA DIVERSION ADMINISTRATOR's -start by reading the manual.
And then do us all a favor:
Step aside.
Start with Section 5202.5.
Then read 5201.12.
And then, resign.
Because no agency can lead while being led by someone who doesn't follow their own manual.
MMJ is represented by attorney Megan Sheehan.
CONTACT:
Madison Hisey
[email protected]
203-231-8583
SOURCE: MMJ International Holdings
View the original press release on ACCESS Newswire
J.Williams--AMWN